Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-04 · accession 0001193125-26-094296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-04 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $17.96 | -139 | 22.6K | -0.6% | -$2,496 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | S | D | 139 | $17.96 | 22,554 | D | — | — |